The use of powdered whole milk in ByHeart infant formula may be linked to a troubling outbreak of botulism, according to recent tests conducted by U.S. health officials. This alarming situation has resulted in dozens of infants falling ill, and investigations are still ongoing to pinpoint the exact source of this contamination.
The U.S. Food and Drug Administration (FDA) reported that they discovered the type of bacteria responsible for causing botulism in two samples associated with ByHeart's formula. Notably, they found that bacteria from an unopened container of the formula matched a sample taken from an infant who became sick, as well as contamination discovered in organic whole milk powder supplied for the formula's production.
Additionally, the FDA's analysis revealed that a sample of whole milk powder provided to ByHeart matched the harmful bacteria found in a finished product, further complicating the situation. However, it’s important to note that these findings do not definitively conclude the investigation; officials have stated that they continue to seek clarity on how the contamination occurred.
Dr. Devon Kuehn, ByHeart’s chief scientific and medical officer, commented on the situation, describing it as a pivotal moment for the company. "We are focused on identifying the root cause and understand our responsibility to implement what we've learned to foster a safer future for both ByHeart and the infant formula market," she said.
At this time, neither the FDA nor ByHeart has disclosed the identity of the supplier responsible for the powdered whole milk. Fortunately, the FDA has indicated that there isn't evidence of a broader issue affecting the infant formula supply overall.
ByHeart, based in New York, has been at the forefront of a significant food poisoning incident, with a total of 51 infants across 19 states affected since December 2023. The first signs of trouble emerged in November when California health officials, who oversee treatment for infant botulism, noticed a spike in cases among babies who consumed ByHeart products.
Encouragingly, the U.S. Centers for Disease Control and Prevention has reported that no additional cases have surfaced since mid-December.
Initially, ByHeart recalled two specific lots of their formula but soon expanded this recall to encompass all their products after federal health officials expressed concerns about potential contamination dating back to the company's launch in March 2022. This decision came after internal testing revealed that six out of thirty-six samples taken from three different lots contained the dangerous bacteria responsible for infant botulism.
Botulism-related illnesses in infant formula are quite rare; however, the extent of the ByHeart outbreak is unprecedented, according to food safety experts. While some formula manufacturers routinely test their raw materials and final products for such contaminants, it is argued that such testing should be mandatory across the industry. Sarah Sorscher, director of regulatory affairs at the Center for Science in the Public Interest, emphasized that the FDA has yet to announce a comprehensive testing plan, which is something advocates want to see implemented.
Even if the source of contamination is traced back to a milk supplier, legal responsibility still lies with ByHeart, asserts Bill Marler, a food safety attorney representing numerous families affected by this outbreak. "Pointing fingers at the dried powder doesn’t absolve ByHeart of its legal or moral obligations," Marler stated.
Despite accounting for only about 1% of the U.S. infant formula market, ByHeart was previously distributing approximately 200,000 cans of its product each month. The formula was marketed as a close alternative to human breast milk, featuring "organic, grass-fed whole milk" as its main ingredient. Parents whose infants have fallen ill selected this formula, priced at around $42 per can, believing in its purported health benefits.
This situation raises many questions about the safety protocols in place for infant formula production and the responsibilities of manufacturers in ensuring the well-being of vulnerable consumers. What do you think—should stricter regulations be enforced for infant formula testing? Or do you believe that the current measures are adequate? Share your thoughts below!
